# Andorra Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Andorra HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Andorra (AND)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $646.3K
- Products: 13
- Buyer markets: 31
- Average CAGR: -2.5%
- Global sector size: $285.3B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $217.8B | $49.5K | $84.7B | +4.4% | 26 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $31.7B | $132.8K | $13.2B | +0.7% | 13 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $12.0B | $271.5K | $6.7B | -5.3% | 6 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $10.5B | $13.2K | $5.2B | -19.0% | 6 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $4.0B | $24.6K | $2.5B | -4.9% | 3 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $241.7 | $1.4B | -28.0% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $2.1B | $69.5K | $1.2B | +22.8% | 2 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $2.2B | $431.5 | $833.8M | -21.1% | 1 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $1.2B | $30.2 | $688.8M | -43.1% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $632.8M | $52.5 | $499.0M | -13.9% | 1 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $813.6M | $1.9 | $493.6M | -29.4% | 1 | +0.0% |
| HS 340130 - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap | $381.9M | $214.1 | $409.5M | -37.2% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $979.8M | $84.3K | $389.1M | +6.5% | 1 | +0.0% |

## Best markets

- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- Spain (ESP): $9.8B calculated opportunity across 7 products.
- Germany (DEU): $8.4B calculated opportunity across 4 products.
- Canada (CAN): $7.5B calculated opportunity across 5 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- France (FRA): $6.2B calculated opportunity across 5 products.
- Italy (ITA): $6.0B calculated opportunity across 3 products.
- Netherlands (NLD): $5.9B calculated opportunity across 2 products.
- United Kingdom (GBR): $5.3B calculated opportunity across 3 products.
- USA, Puerto Rico and US Virgin Islands (USA): $4.5B calculated opportunity across 2 products.
- Japan (JPN): $4.4B calculated opportunity across 2 products.
- China (CHN): $4.1B calculated opportunity across 1 products.

## Growth stars

- HS 330290: +22.8% average CAGR, $1.2B calculated opportunity.
- HS 300290: +6.5% average CAGR, $389.1M calculated opportunity.
- HS 300490: +4.4% average CAGR, $84.7B calculated opportunity.
- HS 330499: +0.7% average CAGR, $13.2B calculated opportunity.
- HS 382499: -4.9% average CAGR, $2.5B calculated opportunity.
- HS 330300: -5.3% average CAGR, $6.7B calculated opportunity.
- HS 300390: -13.9% average CAGR, $499.0M calculated opportunity.
- HS 382200: -19.0% average CAGR, $5.2B calculated opportunity.
- HS 381800: -21.1% average CAGR, $833.8M calculated opportunity.
- HS 340220: -28.0% average CAGR, $1.4B calculated opportunity.

## Diversification opportunities

- HS 300490: 26 buyer markets, $84.7B calculated opportunity.
- HS 330499: 13 buyer markets, $13.2B calculated opportunity.
- HS 330300: 6 buyer markets, $6.7B calculated opportunity.
- HS 382200: 6 buyer markets, $5.2B calculated opportunity.
- HS 382499: 3 buyer markets, $2.5B calculated opportunity.
- HS 330290: 2 buyer markets, $1.2B calculated opportunity.
- HS 340220: 1 buyer markets, $1.4B calculated opportunity.
- HS 381800: 1 buyer markets, $833.8M calculated opportunity.
- HS 300439: 1 buyer markets, $688.8M calculated opportunity.
- HS 300390: 1 buyer markets, $499.0M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.
